Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.
about
Nanotechnology-based cosmeceuticalsDrug delivery systems, CNS protection, and the blood brain barrierAtomic force microscopy study of the specific adhesion between a colloid particle and a living melanoma cell: Effect of the charge and the hydrophobicity of the particle surfaceTransdermal deferoxamine prevents pressure-induced diabetic ulcers.Potential technique for tiny crystalline detection in lycopene-loaded SLN and NLC development.Single and dual drug release patterns from shellac wax-lutrol matrix tablets fabricated with fusion and molding techniques.Characterization and exposure measurement for indium oxide nanofibers generated as byproducts in the LED manufacturing environment.Immune cell recruitment and cell-based system for cancer therapy.Design, characterization, and biological evaluation of curcumin-loaded surfactant-based systems for topical drug delivery.Nanotechnology-based drug delivery systems and herbal medicines: a review.From conventional towards new - natural surfactants in drug delivery systems design: current status and perspectives.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery.Nanocarriers for oral drug delivery.Nanogels for delivery, imaging and therapy.In Vitro Drug and Gene Delivery Using Random Cationic Copolymers Forming Stable and pH-Sensitive Polymersomes.Microscopic methods in analysis of submicron phospholipid dispersions.Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.Lipid-based nanocarriers for the oral administration of biopharmaceutics.Physicochemical characterization of drug nanocarriers.Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.Physicochemical performances of indomethacin in cholesteryl cetyl carbonate liquid crystal as a transdermal dosageQuercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.Analytical electron microscopy for characterization of fluid or semi-solid multiphase systems containing nanoparticulate material.Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea.Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.Acute and subchronic toxicity evaluation of poly(ε-caprolactone) lipid-core nanocapsules in rats.Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.Anti-fungal efficacy of polybutylcyanoacrylate nanoparticles of allicin and comparison with pure allicin.Task-specific, biodegradable amino acid ionic liquid surfactants.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.Orientation-shape coupling between liquid crystal and membrane through the anchoring effect.Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.Exposure Characteristics of Nanoparticles as Process By-products for the Semiconductor Manufacturing Industry.Characterization and stability study of a water-in-oil microemulsion incorporating quercetin.
P2860
Q26828457-66CAF41B-B70B-47F3-9414-FDCC4983BC73Q30432845-C0FF7EE3-7699-4595-8831-1685E4E4B687Q33244983-CDE0794C-0518-4D7E-AD74-B3085A37DCA0Q34926164-4F3D7468-0633-4761-BE0D-433A4DE091F5Q34928496-9AD26A4A-3864-4739-A156-B17817559E20Q35166232-A44CFC86-43BF-4972-9FA2-7974392D85DEQ35792065-3FEB20C6-0864-42D3-8B10-DAE7E9EC139AQ36517706-57F14B2F-57FC-4624-BE2D-3E56CF8B8058Q37249022-4864AE61-565C-4E09-86C2-7EDAB75EA2D3Q37391136-59012E7C-87E3-47E3-B342-78F18EA5B9F6Q37702256-73A95919-AAEF-4279-8E94-04265247182AQ37769529-3C5A0C9D-39CB-4983-9DD9-C0F82866FDA1Q37928912-1ECE9568-6C6B-4EEE-B203-9BEEE11F3C14Q38100238-BA63A605-A6DC-47A4-9583-FA90788A9507Q38101960-175EDB14-3617-4CDB-BA0C-27771DD613B1Q38315170-F45757E1-37D7-462F-922C-A316F930DC73Q38729369-C7FA5EC6-EAFC-4361-A098-F7B3DAE3B2EBQ38766994-0AB94B29-B1E0-4FE4-8F4F-FE2164C11F63Q38938549-3DEF518A-AE64-4B71-AA97-82058CE6D257Q38990887-AEBBB846-CFE2-46E9-AEE7-C88C62D85895Q41057564-CDFF7E21-E3CB-4479-A766-6BDF2515D235Q41859594-1DD98DE2-E909-4AEB-91B3-52DC623EB6ECQ41988331-1A5A3CFE-2009-40ED-8879-F70323373E75Q41989604-B9FBA65B-AB27-442C-8CE3-04430788A0DFQ42843043-A9A8ACFC-DAD1-43B5-819A-3D11E64B1056Q42876078-791BB22B-1106-4842-AB35-0D9AF1EDDAF1Q43245682-F48272C3-5D37-4FA1-BE89-0CD20DEC441CQ43259069-F07D8618-4250-40D9-B108-BCFE9EC4CCFAQ43450285-7DDC11A2-64EC-4D28-93C7-14078E12CC93Q45827964-CD73CAA0-F4E7-480F-AF74-6009B447F375Q46184844-16809340-A7B7-44FB-BBFF-80254F23C860Q46784457-9A9826EB-014B-4112-B3AB-A1EAD9B503AEQ47447720-D0CD8407-C5B3-4462-B0C3-D51FC0812250Q47576736-4BD74FAF-BD9F-4D10-894B-4A264CA0E19AQ49384897-75BA814C-C64B-42E4-B1A8-7AB8656A65D9Q49957086-A4B2D9C0-00EB-4C18-A467-6095FFED4744Q51043920-49E63194-5411-4CC1-9080-FF7049771248Q51286120-27EED0E6-95F7-486F-BFE3-89B2269DA0ECQ53296884-76AC14DD-A3B1-45DF-B0A3-755DE7392BF7Q53930875-0A6F9EAA-2D90-4E22-B724-67AEE1545F0E
P2860
Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Physicochemical characterizati ...... es for topical administration.
@ast
Physicochemical characterizati ...... es for topical administration.
@en
type
label
Physicochemical characterizati ...... es for topical administration.
@ast
Physicochemical characterizati ...... es for topical administration.
@en
prefLabel
Physicochemical characterizati ...... es for topical administration.
@ast
Physicochemical characterizati ...... es for topical administration.
@en
P921
P1476
Physicochemical characterizati ...... es for topical administration.
@en
P2093
C C Müller-Goymann
P304
P356
10.1016/J.EJPB.2004.03.028
P407
P577
2004-09-01T00:00:00Z